Not just for years but for decades, the department of radiology at the University of Wisconsin School of Medicine and Public Health in Madison has been leading the charge on creating innovative technology and translating imaging research into clinical practice.
Countless predictions have been made about artificial intelligence and machine learning changing imaging screening and diagnosis at the point of patient care—and clinical studies and experience are now proving it. Radiologists say the impact is real in improving diagnosis of cancers and quality of care, consistency among readers and reducing read times and unnecessary biopsies. One shining example targets the evaluation of breast ultrasound imaging.
Smart technologies are often touted as the answer to some of cardiology’s greatest challenges in patient care and practice. But where does hyperbole end and reality begin with artificial intelligence, machine learning and deep learning?
Developments in vastly scalable IT infrastructure will soon increase the rate at which machine learning systems gain the capacity to transform the field of medical imaging across clinical, operational and business domains. Moreover, if the pace seems to be picking up, that’s because data management on a massive scale has advanced exponentially over just the past several years.
A new project is seeking to make MRI scans up to 10 times faster by capturing less data. NYU’s Center for Advanced Imaging Innovation and Research (CAI2R) is working with the Facebook Artificial Intelligence Research group to “train artificial neural networks to recognize the underlying structure of the images to fill in views omitted from the accelerated scan.”
Machine learning is one of the hottest topics in radiology and all of healthcare, but reading the latest and greatest ML research can be difficult, even for experienced medical professionals. A new analysis written by a team at Northern Ireland’s Belfast City Hospital and published in the American Journal of Roentgenology was written with that very problem in mind.
As an integrated health-delivery network comprising 13 hospital campuses, two research centers and a health plan with more than half a million subscribers sitting atop the biggest biobank with whole exome (DNA) sequence data in existence, Pennsylvania’s Geisinger Health System is one of the best-positioned institutions in the U.S. to explore the possibilities and initial successes of AI in healthcare. The institution is bringing complex algorithmic concepts to everyday patient care and showing others the path forward.
It’s all about the data. We’ve been saying this for years. We can choose to look at this in one of two ways. It’s either a constant truism or it actually evolves and gains mass over time. In the age of artificial intelligence, it is both.
Medical imaging is in a big battle with big data. There’s too much data in too many locations, and most often they are not well managed. Data are clearly imaging’s most abundant yet most underutilized strategic asset.
Like every American academic healthcare institution, SUNY Downstate Medical Center in Brooklyn, N.Y., is a beehive of activity in three overlapping yet distinct areas of focus—patient care, physician education and medical research.